Navigating the rising wave against non-competes

Non-competes and other restrictive covenants faced a tidal wave of criticism this year, from the White House to state legislatures. The Federal Trade Commission (FTC) is not waiting to finalise or debate its proposed non-compete ban before stepping up enforcement against businesses.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Cigna pursues trade secrets in ‘non-competes’ dispute

31 January 2023 Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.

Americas

AltaThera hits competitor with trade secret suit

1 September 2022 Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Barnes & Thornburg reveals five new IP leaders

Former PTAB judge joins Sterne Kessler

Navigating the rising wave against non-competes

More on this story

Editor's picks

Editor's picks

More features